OMICS International Fined Over $50 Million for “Deceptive Practices”

The publisher and conference organizer is ordered to pay the US government for what some report to be predatory behavior.

Written byChia-Yi Hou
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM
VLADIMIR CETINSKI

US District of Nevada Judge Gloria M. Navarro has ordered OMICS International to pay the US government fines to the amount of over $50 million, according to a court report released March 29.

OMICS is a publisher and conference organizer, and has been reported to engage in predatory publishing. According to the OMICS website, they publish over 700 journals and organize over 3,000 conferences globally. Topics covered include medicine, pharma, engineering, science, technology, and business.

OMICS also claims to have over 50,000 leading experts as editors for their journals. Scientists who were listed have reported they never received manuscripts to review or were not aware of their names being on the editors list, Ars Technica reports.

“I am neither on the rolls of OMICS nor am I the editor of any of those journals. I didn’t even know that they were using my name on their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies